XIIlab씨이랩

XIIlab remains loss-making on a trailing basis, with revenue growing but operating losses still deep as of H1 2026.

XIIlab, a KOSDAQ-listed software company, reported trailing twelve-month revenue of about ₩11.9B and an operating loss of about ₩5.6B through H1 2026, an operating margin of -46.7%. Its shares closed at ₩9,300 on 2026-10-13, roughly ₩87B market cap, after a 19.4% fall over one month but a 77.5% gain over one year. The data does not include a company profile, news headlines, or valuation based on earnings.

What stands out

• Revenue has been volatile: ₩10.3B in 2025 (up 13%), ₩9.1B in 2024 (up 148%), and ₩3.7B in 2023 (down 63%).
• Losses narrowed in 2025 to an operating loss of about ₩3.2B from about ₩5.3B in 2024, though the business still lost money in every year shown from 2021 to 2025.
• Cash of about ₩2.5B against trailing free cash flow of about -₩4.7B suggests the company is burning cash; no borrowings are reported.
• Price-to-book is 4.2 and price-to-sales is 7.3, while P/E cannot be computed because earnings are negative; the data includes no fair value estimate.
• Recent filings are mainly sales or supply contracts (Aug to Oct 2026) and stock option grant notices, with no news headlines in the data.

What to watch

• The next half-year or annual report, to see whether losses keep narrowing and whether cash burn continues.
• Further disclosures of major sales or supply contracts, to judge whether revenue growth is sustained.
• Cash runway: trailing free cash flow is about -₩4.7B against ₩2.5B of cash, so any funding need or dilution from the option grants would matter.